Treatment with plasmapheresis, immunoglobulins and rituximab for chronic-active antibody-mediated rejection in kidney transplantation: Clinical, immunological and pathological results

Table 6 Analysis of Banff scores at diagnosis in functioning and non-functioning grafts at 24 mo

	PE-IVIG-RTX group(n = 9)		P-value	Control group(n = 12)		P-value
	Functioninggraft(n = 6)	Non-functioning graft(n = 3)		Functioninggraft(n = 8)	Non-functioning graft(n = 4)
Chronic glomerulopathy (cg)	2.5 (1-3)	1 (1-3)	0.57	2.5 (1-3)	1 (0-2)	0.226
Glomerulitis (g)	2 (1-3)	1 (1-3)	0.472	2 (2-3)	1 (0-2)	0.043
Peritubular capillaritis (ptc)	1 (0-2)	1 (0-2)	0.829	0 (0-1)	1 (1-3)	0.037
Microvascular inflammation (g + ptc)	2.5 (2-5)	3 (2-3)	0.269	2.5 (2-3)	2.5 (2-3)	0.727
Interstitial inflammation (ci)	0.5 (0-2)	2 (1-2)	0.131	1 (0-1)	1 (1-2)	0.852
Tubular atrophy (ct)	0 (0-1)	0 (0-0)	0.667	1 (0-1)	1 (1-1)	0.255
Chronicity score (ci + ct)	0.5 (0-2)	2 (1-3)	0.29	1.5 (0-3)	2 (1-3)	0.807
C4d+, n (%)	5/7 (71.4)	2/3 (66.7)	0.583	3/8 (37.5)	4/4 (100)	0.071

Data are expressed as median (min-max).